Eli Lilly (LLY) Net Income - Minority (2009 - 2015)

Eli Lilly (LLY) posted Net Income - Minority of -$19.0 million for Q4 2015, down 27.52% quarter-over-quarter from -$14.9 million in Q4 2014, and down 27.52% year-on-year from -$26.2 million in Q4 2014.

Eli Lilly (LLY) Net Income - Minority (2009 - 2015) Analysis & Trends

Eli Lilly (LLY) has reported Net Income - Minority for 6 consecutive years, with -$19.0 million the latest figure, recorded in Q4 2015.

  • Net Income - Minority for Q4 2015 came in at -$19.0 million, down 27.52% year-over-year; the trailing twelve-month figure through Dec 2015 was -$19.0 million (down 27.52% YoY), and the FY2015 annual result was -$19.0 million, down 27.52% from the prior year.
  • Net Income - Minority was -$19.0 million for Q4 2015 at Eli Lilly, down from -$14.9 million in the prior quarter.
  • Over five years, Net Income - Minority peaked at $6.1 million in Q4 2011 and troughed at -$19.0 million in Q4 2015.
  • Average Net Income - Minority over 5 years is -$9.2 million, with a median of -$9.3 million recorded in 2013.
  • Year-over-year, Net Income - Minority slumped 242.62% in 2012 and retreated 6.9% in 2013.
  • Over 5 years, Net Income - Minority stood at $6.1 million in 2011, then plunged by 242.62% to -$8.7 million in 2012, then decreased by 6.9% to -$9.3 million in 2013, then tumbled by 60.22% to -$14.9 million in 2014, then fell by 27.52% to -$19.0 million in 2015.
  • Per Business Quant data, the three most recent Net Income - Minority figures were -$19.0 million in Q4 2015, -$14.9 million in Q4 2014, and -$9.3 million in Q4 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income - Minority (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2015 -19.00 Mn
Dec 31, 2014 -14.90 Mn
Dec 31, 2013 -9.30 Mn
Dec 31, 2012 -8.70 Mn
Dec 31, 2011 6.10 Mn
Sep 30, 2009 -400,000.00